Prevention of fetal bowel allograft rejection by combined treatment with anti-ICAM-1 and anti-LFA-1 antibodies
- 31 July 1995
- journal article
- research article
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 30 (7) , 1093-1097
- https://doi.org/10.1016/0022-3468(95)90349-6
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The effect of anti-ICAM-1 monoclonal antibody treatment on the transplantation of the small bowel in ratsJournal of Pediatric Surgery, 1993
- A PHASE I TRIAL OF IMMUNOSUPPRESSION WITH ANTIIC AM-1 (CD54) mAb IN RENAL ALLOGRAFT RECIPIENTSTransplantation, 1993
- MONOCLONAL ANTIBODIES AGAINST HUMAN T CELL ADHESION MOLECULES—MODULATION OF IMMUNE FUNCTION IN NONHUMAN PRIMATESTransplantation, 1992
- Specific Acceptance of Cardiac Allograft After Treatment with Antibodies to ICAM-1 and LFA-1Science, 1992
- Role of Lymphocyte Adhesion Receptors in Transient Interactions and Cell LocomotionAnnual Review of Immunology, 1991
- Adhesion receptors of the immune systemNature, 1990
- MALA‐2, mouse homologue of human adhesion molecule ICAM‐1 (CD54)European Journal of Immunology, 1989
- Cotransfection of ICAM-1 and HLA-DR reconstitutes human antigen-presenting cell function in mouse L cellsNature, 1989
- The role of lymphokine-activated cell-associated antigenCellular Immunology, 1987
- Lymphokine-activated cell-associated antigen involved in broad-reactive killer cell-mediated cytotoxicityCellular Immunology, 1985